GeoPolitics Pulse

The Heartbeat of World events

Henlius Receives European Orphan Drug Designation for Anti-HER2 Therapy HLX22 …

by ·

Henlius has received Orphan Drug Designation (ODD) for its anti-HER2 targeted treatment, HLX22, from the European Commission. … European Union. The …Read More

Related posts:

  1. European Commission Grants NLX-112 Orphan Medicinal Product Designation … – NeurologyLive
  2. European Commission Adopts Positive Decision for Orphan Medicinal Product Designation …
  3. European Commission Adopts Positive Decision for Orphan Medicinal Product Designation …
  4. European Medicines Agency (EMA) Validates Henlius and Organon Filing for Perjeta …
  5. Counter Terrorism Designations and Designation Update; Iran-related Designation Update